NASDAQ:TOI charts & data provided by TradingView

Latest Insights on TOI

toilet paper shortage What a Shortage of Toilet Paper Can Tell Us About Stocks
by Clint Lee March 18, 2020 2020 Financial Crisis, Big Picture. Big Profits., Investing, Wealth Protection
[3-minute read] On Wall Street and Main Street … emotions are running wild.
The market has seen so many dead cat bounces lately that these cats aren’t just bouncing … they’re dancing. Don’t be hypnotized — it’s a trap! Econ Recon; Jobs at Amazon; Theaters Be Gone
by Joseph Hargett March 17, 2020 Great Stuff
Dead Cats Can Dance Initial reports on the U.S. economy started rolling in this morning … and I’m not sure if you really want to look or not. The New York Federal Reserve’s Empire State Manufacturing Index plunged by the biggest margin on record: 34.4 points. The reading, which now stands at -21.5, indicates contraction […]
Nothing says “market confidence” like two interest rate cuts in less than a month. Great Stuff has you covered — with stock market confidence to spare. Fed on the Run; Apple Stunned; Airlines Plunge
by Joseph Hargett March 16, 2020 Great Stuff
When the Fed Hits the Fan… Anyone else feel like they’re stuck in a time loop? This morning, U.S. futures trading halted after hitting a down-limit loss of 5% … again. Then, immediately after the markets opened for regular trading, stocks plunged 8% to trigger another halt … again. This fresh round of Wall Street […]
What we’ve got here is failure to communicate. Wall Street is saying loud and clear that it is not happy with last night’s speech. Travel Bans and Broken Circuit Breakers
by Joseph Hargett March 12, 2020 2020 Financial Crisis, Great Stuff
Rolling in the Deep Double the circuit breakers, double the fun? For the second time this week, trading halted on Wall Street — both in futures trading and during the regular session. Welcome to the bear market. Sparking the chaos this time around was President Trump’s less-than-reassuring and confusing response to the growing COVID-19 threat. […]
abbvie stock Profit From AbbVie’s Struggles Today
by Chad Shoop February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

Share This